Monlan, Vanjelyn B.

HRN: 22-45-34  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/04/2023
CEFTRIAXONE 1G (VIAL)
01/04/2023
01/10/2023
IV
2gm
Q24
UTI
Waiting Final Action 
01/05/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
01/05/2023
01/11/2023
IV
4.5g
Q6h
UTI In Severe Dehydration
Waiting Final Action 
01/08/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
01/08/2023
01/14/2023
IV
600 Mg
Q8H
CAP-ME
Waiting Final Action 
01/10/2023
FLUCONAZOLE 150MG (CAP)
01/10/2023
01/16/2023
PO
150mg
OD
T/C Fungal Infection, Lung Abscess Left, PTB
Waiting Final Action 
01/13/2023
CEFTRIAXONE 1G (VIAL)
01/13/2023
01/19/2023
IVT
2gms
Q12
Cap Mr
Waiting Final Action 
01/17/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
01/17/2023
01/23/2023
IV
750 Mg
Q8H
TB Meningitis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: